DARE BIOSCIENCE INC's ticker is DARE and the CUSIP is 23666P101. A total of 36 filers reported holding DARE BIOSCIENCE INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,141 | -48.3% | 15,302 | -24.6% | 0.00% | – |
| Q1 2024 | $9,949 | +26.1% | 20,304 | -20.5% | 0.00% | – |
| Q4 2023 | $7,887 | -16.4% | 25,524 | +24.9% | 0.00% | – |
| Q3 2023 | $9,438 | +5.1% | 20,429 | +107.1% | 0.00% | – |
| Q2 2023 | $8,978 | +52711.8% | 9,866 | -41.6% | 0.00% | -100.0% |
| Q1 2023 | $17 | +30.8% | 16,885 | +11.3% | 0.00% | 0.0% |
| Q4 2022 | $13 | -99.9% | 15,168 | -39.2% | 0.00% | – |
| Q3 2022 | $25,000 | -16.7% | 24,942 | +1.2% | 0.00% | -100.0% |
| Q2 2022 | $30,000 | -51.6% | 24,653 | -41.3% | 0.00% | 0.0% |
| Q1 2022 | $62,000 | -50.0% | 41,968 | -43.5% | 0.00% | -66.7% |
| Q3 2021 | $124,000 | +6100.0% | 74,242 | +6917.2% | 0.00% | – |
| Q2 2021 | $2,000 | -50.0% | 1,058 | -55.9% | 0.00% | – |
| Q1 2021 | $4,000 | -33.3% | 2,398 | -49.8% | 0.00% | – |
| Q4 2020 | $6,000 | -50.0% | 4,774 | -61.0% | 0.00% | – |
| Q3 2020 | $12,000 | -7.7% | 12,227 | -8.9% | 0.00% | -100.0% |
| Q2 2020 | $13,000 | – | 13,420 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 326,243 | $706,000 | 0.62% |
| Rock Springs Capital Management LP | 62,500 | $135,000 | 0.01% |
| Artemis Wealth Advisors, LLC | 1,762 | $1,905 | 0.00% |
| Inspire Investing, LLC | 403 | $1,000 | 0.00% |
| UBS Group AG | 4,244 | $9,000 | 0.00% |
| WASHINGTON TRUST BANK | 23 | $0 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 5,848 | $13,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 11,467 | $25,000 | 0.00% |
| BlackRock Inc. | 643 | $1,000 | 0.00% |
| Citadel Advisors | 11,280 | $24,000 | 0.00% |